Synthetic Biologics (SYN)

Add to Watchlists
Create an Alert
2.52 +0.03  +1.20% AMEX Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
SYN Price Chart
View All Events

SYN Events

Date Type Description
Mar 31 Misc Synthetic Biologics Inc Q4 2013 Earnings Conference Call
Mar 31 Earnings Synthetic Biologics Inc Q4 2013 Earnings Results. Estimate: -0.06.
Nov 14 Misc Synthetic Biologics to Report Third Quarter 2013 Financial Results Conference Call
Nov 14 Earnings Synthetic Biologics to Report Third Quarter 2013 Financial Results. Estimate: -0.06.
Aug 14 Misc Synthetic Biologics to Host Second Quarter 2013 Financial Conference Call
Aug 14 Earnings Synthetic Biologics to Report Second Quarter 2013 Financial Results. Estimate: -0.06.
Jun 25 Misc Synthetic Biologics to Host Multiple Sclerosis-estriol Investor Day in New York City on June 25, 2013
May 15 Earnings Synthetic Biologics Reports First Quarter 2013 Financial Results. Estimate: -0.05.
View All Performance Charts

SYN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Synthetic Biologics is up 61.54% over the last year vs S&P 500 Total Return up 22.72%, Intrexon Corp up N/A, and Actelion up 72.03%.

Get Quote for
Advertisement

Portfolio Strategies Featuring SYN

Did Synthetic Biologics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SYN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Synthetic Biologics Inc. is a biotechnology company engaged in the development of biologics for the prevention and treatment of serious infectious diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SYN 2.52 +0.03 +1.20% 146.86M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.